Adenocard

Last updated on RxList: 9/8/2020
Adenocard Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

What Is Adenocard?

Adenocard IV (adenosine) Injection is an antiarrhythmic drug used to treat paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome). Adenocard IV is available in generic form.

What Are Side Effects of Adenocard?

Common side effects of Adenocard IV include:

Dosage for Adenocard

The initial adult dose of Adenocard IV is 6 mg given as a rapid intravenous bolus (administered over a 1-2 second period). If the first dose does not result in elimination of the supraventricular tachycardia within 1-2 minutes, 12 mg should be given as a rapid intravenous bolus.

What Drugs, Substances, or Supplements Interact with Adenocard?

Adenocard IV may interact with digoxin, verapamil, digitalis, caffeine, theophylline, dipyridamole, or carbamazepine. Tell your doctor all medications and supplements you use.

Adenocard During Pregnancy and Breastfeeding

During pregnancy, Adenocard IV should be used only if prescribed. Consult your doctor before breastfeeding.

Additional Information

Our Adenocard IV (adenosine) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

QUESTION

In the U.S., 1 in every 4 deaths is caused by heart disease. See Answer
Adenocard Consumer Information

3 pharmacies near 20147 have coupons for adenocard (Brand Names:Adenocard I.V. for 2ML of 6MG/2ML)

Wegmans Food Markets Inc
Wegmans Food Markets Inc
$49.19

Est. Regular Price

$11.19

with free coupon

View Coupon

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Tell your caregivers right away if you have:

  • severe shortness of breath;
  • chest pain or tightness, pain spreading to your jaw or shoulder;
  • fluttering in your chest;
  • a light-headed feeling, like you might pass out;
  • a seizure;
  • severe headache, blurred vision, pounding in your neck or ears; or
  • sudden numbness or weakness, problems with vision or speech.

Common side effects may include:

  • flushing (sudden warmth, redness, or tingly feeling);
  • chest pressure, shortness of breath;
  • nausea;
  • headache, dizziness; or
  • discomfort in your neck or jaw.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Adenocard (Adenosine)

SLIDESHOW

Heart Disease: Symptoms, Signs, and Causes See Slideshow
Adenocard Professional Information

SIDE EFFECTS

The following reactions were reported with intravenous Adenocard (adenosine injection) used in controlled U.S. clinical trials. The placebo group had a less than 1% rate of all of these reactions.

Cardiovascular

Facial flushing (18%), headache (2%), sweating, palpitations, chest pain, hypotension (less than 1%).

Respiratory

Shortness of breath/dyspnea (12%), chest pressure (7%), hyperventilation, head pressure (less than 1%).

Central Nervous System

Lightheadedness (2%), dizziness, tingling in arms, numbness (1%), apprehension, blurred vision, burning sensation, heaviness in arms, neck and back pain (less than 1%).

Gastrointestinal

Nausea (3%), metallic taste, tightness in throat, pressure in groin (less than 1%).

Post Marketing Experience

(see WARNINGS)

The following adverse events have been reported from marketing experience with Adenocard. Because these events are reported voluntarily from a population of uncertain size, are associated with concomitant diseases and multiple drug therapies and surgical procedures, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Decisions to include these events in labeling are typically based on one or more of the following factors: (1) seriousness of the event, (2) frequency of the reporting, (3) strength of causal connection to the drug, or a combination of these factors.

Cardiovascular

Prolonged asystole, ventricular tachycardia, ventricular fibrillation, transient increase in blood pressure, bradycardia, atrial fibrillation, and Torsade de Pointes

Respiratory

Bronchospasm

Central Nervous System

Seizure activity, including tonic clonic (grand mal) seizures, and loss of consciousness.

Read the entire FDA prescribing information for Adenocard (Adenosine)

IMAGES

See Images

© Adenocard Patient Information is supplied by Cerner Multum, Inc. and Adenocard Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors